Cost of managing an episode of relapse in multiple sclerosis in the United States
<p>Abstract</p> <p>Background</p> <p>The purpose of this study was to determine the direct medical US cost of managing multiple sclerosis relapses.</p> <p>Methods</p> <p>Direct data analysis and cost modeling were employed to derive typical resou...
Main Authors: | Ward Alexandra J, O'Brien Judith A, Patrick Amanda R, Caro Jaime |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2003-09-01
|
Series: | BMC Health Services Research |
Online Access: | http://www.biomedcentral.com/1472-6963/3/17 |
Similar Items
-
Longitudinal analysis of verbal episodic memory in patients with relapsing-remitting multiple sclerosis
by: Izadora Nogueira Fonte Boa, et al. -
Relapses In multiple sclerosis.
by: O. O. Nikolenko, et al.
Published: (2019-11-01) -
Spontaneous and induced cerebral plasticity during autobiographical memory and episodic future thinking performance in relapsing-remitting multiple sclerosis patients
by: Ernst, Alexandra
Published: (2014) -
The cost-effectiveness of alemtuzumab in the management of relapse-remitting multiple sclerosis in Italy
by: Sanja Stanisic, et al.
Published: (2019-04-01) -
Cost of managing complications resulting from type 2 diabetes mellitus in Canada
by: Patrick Amanda R, et al.
Published: (2003-03-01)